Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:teichoic acid
go back to main search page
Accession:CHEBI:30049 term browser browse the term
Definition:Bacterial polysaccharide derivatives of glycerol phosphate or ribitol phosphate linked via phosphodiester bonds, whose main function is to fortify the cell wall. In some parasites, they serve as a site of attachment to mucosal membranes.
Synonyms:related_synonym: TAs;   teichoic acids
 alt_id: CHEBI:26866;   CHEBI:9431
 xref: KEGG:C06707;   PMID:18327271;   PMID:19229300;   PMID:19899094;   Wikipedia:Teichoic_acid


show annotations for term's descendants           Sort by:
lipoteichoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKT1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation		 ISO Genistein inhibits the reaction [lipoteichoic acid results in increased phosphorylation of AKT1 protein]; Luteolin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of AKT1 protein]; quercetagetin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of AKT1 protein]; Quercetin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of AKT1 protein] CTD PMID:20685402 PMID:23500011 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759 		JBrowse link
G ALB albumin multiple interactions ISO ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]] CTD PMID:19376148 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 increases secretion
increases expression
multiple interactions		 EXP
ISO		 lipoteichoic acid results in increased secretion of CCL2 protein
lipoteichoic acid results in increased expression of CCL2 protein
resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CCL2 protein]		 CTD PMID:23981542 PMID:29311626 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208 		JBrowse link
G CCL20 C-C motif chemokine ligand 20 increases secretion ISO lipoteichoic acid results in increased secretion of CCL20 protein CTD PMID:15618187 NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564 		JBrowse link
G CREB1 cAMP responsive element binding protein 1 multiple interactions ISO [Particulate Matter co-treated with lipoteichoic acid] results in increased expression of CREB1 mRNA; [Vehicle Emissions co-treated with lipoteichoic acid] results in increased expression of CREB1 mRNA CTD PMID:19653804 NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988 		JBrowse link
G CSF2 colony stimulating factor 2 multiple interactions
increases secretion		 EXP Dexamethasone inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein]; resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein] CTD PMID:23981542 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170 		JBrowse link
G CXCL2 C-X-C motif chemokine ligand 2 increases expression ISO lipoteichoic acid results in increased expression of CXCL2 protein CTD PMID:29311626 NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases secretion
multiple interactions		 EXP lipoteichoic acid results in increased secretion of CXCL8 protein
resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CXCL8 protein]		 CTD PMID:22183712 PMID:23981542 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CXCR2 C-X-C motif chemokine receptor 2 decreases expression EXP lipoteichoic acid results in decreased expression of CXCR2 protein CTD PMID:10950785 NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251 		JBrowse link
G ELANE elastase, neutrophil expressed increases secretion
multiple interactions		 EXP lipoteichoic acid results in increased secretion of ELANE protein
Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of ELANE protein]		 CTD PMID:11302825 NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247 		JBrowse link
G GRIN1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions ISO [Particulate Matter co-treated with lipoteichoic acid] results in increased expression of GRIN1 mRNA; [Vehicle Emissions co-treated with lipoteichoic acid] results in increased expression of GRIN1 mRNA CTD PMID:18926851 NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756 		JBrowse link
G GRIN2A glutamate ionotropic receptor NMDA type subunit 2A multiple interactions ISO [Particulate Matter co-treated with lipoteichoic acid] results in increased expression of GRIN2A mRNA; [Vehicle Emissions co-treated with lipoteichoic acid] results in increased expression of GRIN2A mRNA CTD PMID:18926851 PMID:19653804 NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,183,337 		JBrowse link
G GRIN2B glutamate ionotropic receptor NMDA type subunit 2B increases expression
multiple interactions		 ISO lipoteichoic acid results in increased expression of GRIN2B mRNA
[Particulate Matter co-treated with lipoteichoic acid] results in increased expression of GRIN2B mRNA; [Vehicle Emissions co-treated with lipoteichoic acid] results in increased expression of GRIN2B mRNA; Particulate Matter promotes the reaction [lipoteichoic acid results in increased expression of GRIN2B mRNA]; Vehicle Emissions promotes the reaction [lipoteichoic acid results in increased expression of GRIN2B mRNA]		 CTD PMID:18926851 PMID:19653804 NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002 		JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions
increases expression		 ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lipoteichoic acid results in increased expression of HMOX1 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lipoteichoic acid results in increased expression of HMOX1 protein]; HMOX1 protein inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; prolinedithiocarbamate inhibits the reaction [lipoteichoic acid results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [lipoteichoic acid results in increased expression of HMOX1 protein] CTD PMID:15316927 PMID:23500011 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214 		JBrowse link
G IL10 interleukin 10 increases expression
multiple interactions		 EXP
ISO		 lipoteichoic acid results in increased expression of IL10 protein
lipoteichoic acid results in increased expression of IL10 mRNA; lipoteichoic acid results in increased expression of IL10 protein
Sirolimus inhibits the reaction [lipoteichoic acid results in increased expression of IL10 protein]		 CTD PMID:11169223 PMID:29311626 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541 		JBrowse link
G IL1B interleukin 1 beta multiple interactions
increases expression		 ISO Genistein inhibits the reaction [lipoteichoic acid results in increased expression of IL1B]; Luteolin inhibits the reaction [lipoteichoic acid results in increased expression of IL1B]; quercetagetin inhibits the reaction [lipoteichoic acid results in increased expression of IL1B]; Quercetin inhibits the reaction [lipoteichoic acid results in increased expression of IL1B]
lipoteichoic acid results in increased expression of IL1B; lipoteichoic acid results in increased expression of IL1B mRNA		 CTD PMID:20685402 PMID:29311626 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL4 interleukin 4 increases expression ISO lipoteichoic acid results in increased expression of IL4 mRNA CTD PMID:29311626 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678 		JBrowse link
G IL6 interleukin 6 increases secretion
increases expression
multiple interactions		 EXP
ISO		 lipoteichoic acid results in increased secretion of IL6 protein
lipoteichoic acid results in increased expression of IL6 mRNA
Protein Kinase Inhibitors inhibits the reaction [lipoteichoic acid results in increased expression of IL6 protein]
17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [lipoteichoic acid results in increased expression of IL6 protein]; Protein Kinase Inhibitors inhibits the reaction [lipoteichoic acid results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of IL6 protein]		 CTD PMID:20810098 PMID:23981542 PMID:28003376 PMID:29311626 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G ISG15 ISG15 ubiquitin like modifier increases expression EXP lipoteichoic acid results in increased expression of ISG15 protein CTD PMID:32796029 NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases phosphorylation		 ISO wogonin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of JUN protein] CTD PMID:17570322 PMID:23500011 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048 		JBrowse link
G LTF lactotransferrin increases secretion
multiple interactions		 EXP lipoteichoic acid results in increased secretion of LTF protein
Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein]		 CTD PMID:11302825 NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234 		JBrowse link
G MAP2K1 mitogen-activated protein kinase kinase 1 increases phosphorylation
multiple interactions		 ISO lipoteichoic acid results in increased phosphorylation of MAP2K1 protein
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein]		 CTD PMID:19573522 NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656 		JBrowse link
G MAP2K2 mitogen-activated protein kinase kinase 2 increases phosphorylation
multiple interactions		 ISO lipoteichoic acid results in increased phosphorylation of MAP2K2 protein
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K2 protein]		 CTD PMID:19573522 NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions
increases phosphorylation		 ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]; Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]; zinc protoporphyrin promotes the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]
Genistein inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]; quercetagetin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]; Quercetin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]		 CTD PMID:18845389 PMID:19376148 PMID:19573522 PMID:20685402 PMID:23500011 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation		 ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; zinc protoporphyrin promotes the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]
Genistein inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; Luteolin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; quercetagetin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; Quercetin inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]		 CTD PMID:18845389 PMID:19376148 PMID:19573522 PMID:20685402 PMID:23500011 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions ISO [Chlorpromazine co-treated with lipoteichoic acid] results in increased phosphorylation of MAPK8 protein; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased phosphorylation of MAPK8 protein] CTD PMID:23238562 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360 		JBrowse link
G NFKBIA NFKB inhibitor alpha increases phosphorylation
decreases expression		 ISO lipoteichoic acid results in increased phosphorylation of NFKBIA protein
lipoteichoic acid results in decreased expression of NFKBIA mRNA		 CTD PMID:23500011 PMID:29311626 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G NOS2 nitric oxide synthase 2 increases expression
multiple interactions		 ISO lipoteichoic acid results in increased expression of NOS2 mRNA; lipoteichoic acid results in increased expression of NOS2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; cobaltiprotoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; Curcumin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; HMOX1 protein inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; lactacystin inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; prolinedithiocarbamate inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; pyrazolanthrone inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; pyrazolanthrone inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; SB 203580 inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; tanshinone inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; TLR2 protein affects the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; wogonin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; wogonin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]		 CTD PMID:15316927 PMID:17570322 PMID:19376148 PMID:19497418 PMID:19573522 More... NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 increases expression ISO lipoteichoic acid results in increased expression of PTGS1 mRNA CTD PMID:29311626 NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression		 ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; Curcumin inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; prolinedithiocarbamate inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; pyrazolanthrone inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; SB 203580 inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein]; tanshinone inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein] CTD PMID:23500011 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G RAF1 Raf-1 proto-oncogene, serine/threonine kinase increases phosphorylation
multiple interactions		 ISO lipoteichoic acid results in increased phosphorylation of RAF1 protein
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of RAF1 protein]; TLR2 protein affects the reaction [lipoteichoic acid results in increased phosphorylation of RAF1 protein]		 CTD PMID:19573522 NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit increases phosphorylation ISO lipoteichoic acid results in increased phosphorylation of RELA protein CTD PMID:23500011 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G TIRAP TIR domain containing adaptor protein multiple interactions ISO TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased expression of TNF protein]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased phosphorylation of MAPK8 protein]; TIRAP protein results in increased susceptibility to [Chlorpromazine co-treated with lipoteichoic acid] CTD PMID:23238562 NCBI chr11:126,283,093...126,294,933
Ensembl chr11:126,282,497...126,298,845 		JBrowse link
G TLR2 toll like receptor 2 multiple interactions
increases activity		 ISO
EXP		 [lipoteichoic acid binds to and results in increased activity of TLR2 protein] which results in increased expression of TNF mRNA; lipoteichoic acid binds to and results in increased activity of TLR2 protein; TLR2 protein affects the reaction [lipoteichoic acid results in increased abundance of Nitrites]; TLR2 protein affects the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; TLR2 protein affects the reaction [lipoteichoic acid results in increased phosphorylation of RAF1 protein]
lipoteichoic acid results in increased activity of TLR2 protein		 CTD PMID:18845389 PMID:19573522 PMID:28003376 NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260 		JBrowse link
G TNF tumor necrosis factor multiple interactions
increases secretion
increases expression		 ISO
EXP		 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased expression of and results in increased secretion of TNF protein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased expression of TNF mRNA]; [Chlorpromazine co-treated with lipoteichoic acid] results in increased expression of TNF protein; [lipoteichoic acid binds to and results in increased activity of TLR2 protein] which results in increased expression of TNF mRNA; cinnamaldehyde inhibits the reaction [lipoteichoic acid results in increased secretion of TNF protein]; Dactinomycin promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased expression of TNF mRNA]]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [lipoteichoic acid results in increased secretion of TNF protein]; lipoteichoic acid results in increased expression of and results in increased secretion of TNF protein; Tetradecanoylphorbol Acetate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased expression of and results in increased secretion of TNF protein]]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased expression of TNF protein]
lipoteichoic acid results in increased expression of TNF protein		 CTD PMID:11169223 PMID:15618187 PMID:16373689 PMID:17868967 PMID:18845389 More... NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26503
    chemical entity 26483
      molecular entity 26465
        polyatomic entity 26300
          macromolecule 9623
            biomacromolecule 9138
              polysaccharide derivative 5891
                teichoic acid 35
                  2-O-alanyl-4-O-substituted-D-ribitol teichoic acid 0
                  lipoteichoic acid + 35
                  poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid 0
                  poly(glucosyl N-acetylgalactosamine 1-phosphate) teichoic acid 0
                  poly(glycerol phosphate) teichoic acid 0
                  poly(ribitol phosphate) teichoic acid 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 26503
    subatomic particle 26479
      composite particle 26479
        hadron 26479
          baryon 26479
            nucleon 26479
              atomic nucleus 26479
                atom 26479
                  main group element atom 26216
                    p-block element atom 26216
                      carbon group element atom 25661
                        carbon atom 25623
                          organic molecular entity 25623
                            heteroorganic entity 25006
                              organochalcogen compound 24600
                                organooxygen compound 24194
                                  carbohydrates and carbohydrate derivatives 16821
                                    carbohydrate 16821
                                      polysaccharide 8997
                                        polysaccharide derivative 5891
                                          teichoic acid 35
                                            2-O-alanyl-4-O-substituted-D-ribitol teichoic acid 0
                                            lipoteichoic acid + 35
                                            poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid 0
                                            poly(glucosyl N-acetylgalactosamine 1-phosphate) teichoic acid 0
                                            poly(glycerol phosphate) teichoic acid 0
                                            poly(ribitol phosphate) teichoic acid 0
paths to the root